HCA Healthcare, Inc. (HCA): Price and Financial Metrics
HCA Healthcare, Inc. (HCA)
Today's Latest Price: $109.77 USD
Updated May 28 4:10pm
Add HCA to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 7 in Medical - Hospitals
See all "A" rated Strong Buy stocks
HCA Stock Summary
- HCA Healthcare Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 1.17% of US listed stocks.
- Of note is the ratio of HCA Healthcare Inc's sales and general administrative expense to its total operating expenses; just 0.34% of US stocks have a lower such ratio.
- Equity multiplier, or assets relative to shareholders' equity, comes in at -13.59 for HCA Healthcare Inc; that's greater than it is for just 1.58% of US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to HCA Healthcare Inc are HLT, PSA, DLR, NEM, and EOG.
- Visit HCA's SEC page to see the company's official filings. To visit the company's web site, go to www.hcahealthcare.com.
HCA Stock Price Chart More Charts
HCA Price/Volume Stats
| Current price | $109.77 | 52-week high | $151.97 |
| Prev. close | $113.66 | 52-week low | $58.38 |
| Day low | $109.42 | Volume | 1,724,060 |
| Day high | $115.49 | Avg. volume | 2,789,362 |
| 50-day MA | $100.49 | Dividend yield | 1.51% |
| 200-day MA | $124.98 | Market Cap | 37.06B |
HCA Healthcare, Inc. (HCA) Company Bio
HCA Holdings provides health care services in the United States. It operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services, and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. The company was founded in 1968 and is based in Nashville, Tennessee.
HCA Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $109.77 | $244.53 | 115% |
Below please find a table outlining a discounted cash flow forecast for HCA, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that HCA Healthcare Inc ranked in the 64th percentile in terms of potential gain offered. Moreover, under all the scenarios we modelled, the output consistently forecasted positive returns. The most interesting components of our discounted cash flow analysis for HCA Healthcare Inc ended up being:
- The stock's equity weight, or the proportion of capital from equity relative to debt, is 52. Its equity weight surpasses that of merely 14.52% of free cash flow generating stocks in the Healthcare sector.
- HCA Healthcare Inc's weighted average cost of capital (WACC) is 6%; for context, that number is higher than only 5.7% of tickers in our DCF set.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 111% |
| 1% | 113% |
| 2% | 115% |
| 3% | 117% |
| 4% | 119% |
| 5% | 121% |
For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as HCA, try HUM, ENDP, UTHR, EGRX, and MCK.
Loading social stream, please wait...